AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 258.89 billion. The enterprise value is 305.67 billion.

Market Cap	258.89B
Enterprise Value	305.67B

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Apr 15, 2026

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.33%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 83.24 and the forward PE ratio is 13.90.

PE Ratio	83.24
Forward PE	13.90
PS Ratio	5.70
PB Ratio	-107.94
P/TBV Ratio	n/a
P/FCF Ratio	19.56
P/OCF Ratio	18.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.93, with an EV/FCF ratio of 23.09.

EV / Earnings	98.28
EV / Sales	6.75
EV / EBITDA	13.93
EV / EBIT	19.55
EV / FCF	23.09

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	5.67%
Revenue Per Employee	797,226
Profits Per Employee	54,565
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 1.76 billion in taxes.

Income Tax	1.76B
Effective Tax Rate	35.83%

Stock Price Statistics

The stock price has increased by +5.68% in the last 52 weeks. The beta is 0.36, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	+5.68%
50-Day Moving Average	216.21
200-Day Moving Average	217.95
Relative Strength Index (RSI)	32.78
Average Volume (20 Days)	8,666

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, AbbVie had revenue of GBP 45.44 billion and earned 3.11 billion in profits. Earnings per share was 1.75.

Revenue	45.44B
Gross Profit	32.55B
Operating Income	15.69B
Pretax Income	4.90B
Net Income	3.11B
EBITDA	21.74B
EBIT	15.69B
Earnings Per Share (EPS)	1.75

Balance Sheet

The company has 3.91 billion in cash and 50.82 billion in debt, giving a net cash position of -46.92 billion.

Cash & Cash Equivalents	3.91B
Total Debt	50.82B
Net Cash	-46.92B
Net Cash Per Share	n/a
Equity (Book Value)	-2.40B
Book Value Per Share	-1.37
Working Capital	-10.57B

Cash Flow

In the last 12 months, operating cash flow was 14.14 billion and capital expenditures -902.00 million, giving a free cash flow of 13.24 billion.

Operating Cash Flow	14.14B
Capital Expenditures	-902.00M
Depreciation & Amortization	6.02B
Net Borrowing	-224.91M
Free Cash Flow	13.24B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 5.02, which amounts to a dividend yield of 2.54%.

Dividend Per Share	5.02
Dividend Yield	2.54%
Dividend Growth (YoY)	1.18%
Years of Dividend Growth	11
Payout Ratio	275.84%
Buyback Yield	n/a
Shareholder Yield	2.54%
Earnings Yield	1.20%
FCF Yield	5.11%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8